Overview Financials News + Filings IR Vault Key Docs Charts Transactions Ownership Insiders
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues |
| UNITED STATES | 130.2 | 988.5 | 105.9 | 597.6 | 374.8 | | | |
| Non-US | 894.9 | 566.9 | 431.3 | 184.8 | 121.0 | | | |
| Biothrax | | | | | | 391.0 | 435.5 | |
| |
| EBITDA |
| |
| EBIT |
| |
| Mix |
| UNITED STATES | 7.3% | 63.6% | 9.6% | 76.4% | 66.8% | | | |
| Non-US | 49.9% | 36.4% | 39.0% | 23.6% | 21.6% | | | |
| Biothrax | | | | | | 80.0% | 89.0% | |
| |
| Growth |
| UNITED STATES | -86.8% | 833.4% | -82.3% | 59.4% | | | | |
| Non-US | 57.9% | 31.4% | 133.4% | 52.7% | | | | |
| Biothrax | | | | | | -10.2% | | |
|